Hyperprolactinemia associated with psychotropics--a review

Clicks: 227
ID: 272157
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Clinicians need to be alert about the potential for hyperprolactinemia and its manifestations with these medications. Prolactin levels need to be monitored and other causes of hyperprolactinemia ruled out in suspected cases.
Reference Key
s1970humanhyperprolactinemia Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Madhusoodanan S;Parida S;Jimenez C;;
Journal human psychopharmacology
Year 1970
DOI
DOI not found
URL
https://www.pubmed.gov/20521318/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review animals humans pubmed abstract nih national institutes of health national library of medicine female male Hyperprolactinemia / epidemiology antidepressive agents / adverse effects hyperprolactinemia / metabolism prolactin / blood psychotropic drugs / therapeutic use hyperprolactinemia / drug therapy antipsychotic agents / therapeutic use antidepressive agents / therapeutic use hyperprolactinemia / chemically induced* antipsychotic agents / adverse effects pmid:20521318 doi:10.1002/hup.1116 subramoniam madhusoodanan suprit parida carolina jimenez anti-anxiety agents / adverse effects anti-anxiety agents / therapeutic use mental disorders / drug therapy prolactin / physiology psychotropic drugs / adverse effects*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.